Infectious morbidity in gynecologic oncologic surgery. A clinical and economic evaluation

M. Franchi, S. Salvatore, F. Zanaboni, A. Tusei, E. Scorbati

Research output: Contribution to journalArticlepeer-review

Abstract

In the Department of Obstetrics and Gynecology, Faculty of Medicine, Varese, between March 1991 and February 1992, 70 consecutive patients undergoing elective oncologic surgery were evaluated for rationalizing the use of antibiotics in order to reduce the cost of infectious complications. We divided our patients into two groups: a high infection risk group and a low infection risk group. Our findings show that: the HIR group shows a higher antibiotic cost than the LIR one; our selection criteria for HIR patients are probably correct; in the LIR group 46.6% of patients were not submitted to any antibiotic therapy.

Original languageEnglish
Pages (from-to)23-26
Number of pages4
JournalClinical and Experimental Obstetrics and Gynecology
Volume20
Issue number1
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Infectious morbidity in gynecologic oncologic surgery. A clinical and economic evaluation'. Together they form a unique fingerprint.

Cite this